A
A. Sanchez-Andrade
Publications - 35
Citations - 2035
A. Sanchez-Andrade is an academic researcher. The author has contributed to research in topics: Giant cell arteritis & Population. The author has an hindex of 20, co-authored 33 publications receiving 1871 citations.
Papers
More filters
Journal Article
Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis.
Miguel A. Gonzalez-Gay,J M De Matias,Carlos González-Juanatey,Carlos Garcia-Porrua,A. Sanchez-Andrade,Javier Martin,Javier Llorca +6 more
TL;DR: A rapid beneficial effect of infliximab on insulin resistance and insulin sensitivity in RA patients treated periodically with this drug is confirmed and may support the longterm use of drugs that act blocking TNF-α function to reduce the mechanisms implicated in the development of atherosclerosis in patients with RA.
Journal ArticleDOI
Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.
Miguel A. Gonzalez-Gay,Sonia Barros,Maria J. Lopez-Diaz,Carlos Garcia-Porrua,A. Sanchez-Andrade,Javier Llorca +5 more
TL;DR: The observations confirm the presence of different disease patterns of clinical presentation in GCA and emphasize the importance of an abnormal temporal artery on physical examination and anemia as factors that may predict the risk of severe ischemic complications related to GCA.
Journal ArticleDOI
Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study.
Miguel A. González-Gay,José A. Miranda-Filloy,Maria J. Lopez-Diaz,Roberto Pérez-Alvarez,Carlos González-Juanatey,A. Sanchez-Andrade,Javier Martín,Javier Llorca +7 more
TL;DR: A progressive increase in the incidence of biopsy-proven GCA in northwestern Spain is confirmed, and it is suggested that there has been a change in the clinical spectrum of the disease.
Journal ArticleDOI
Giant cell arteritis : Laboratory tests at the time of diagnosis in a series of 240 patients
Miguel A. González-Gay,Maria J. Lopez-Diaz,Sonia Barros,Carlos Garcia-Porrua,A. Sanchez-Andrade,Jose Paz-Carreira,Javier Martín,Javier Llorca +7 more
TL;DR: It is suggested that some laboratory markers of inflammation, in particular the presence of anemia, may negatively predict the risk of severe ischemic complications in GCA patients.
Journal ArticleDOI
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients
Javier Loricera,Ricardo Blanco,José L. Hernández,Santos Castañeda,Antonio Mera,Eva Perez-Pampin,Peiró E,A. Humbría,Jaime Calvo-Alén,Elena Aurrecoechea,Javier Narváez,A. Sanchez-Andrade,Paloma Vela,Elvira Díez,C. Mata,Pau Lluch,Concepción Moll,Íñigo Hernández,Vanesa Calvo-Río,Francisco Ortiz-Sanjuán,Carmen González-Vela,Trinitario Pina,Miguel A. González-Gay +22 more
TL;DR: TCZ therapy leads to rapid and maintained improvement in patients with refractory GCA and/or with unacceptable side effects related to corticosteroids, however, the risk of infection should be kept in mind when using this drug in Patients with GCA.